Hemicyanine‐Based Near‐Infrared Activatable Probes for Imaging and Diagnosis of Diseases
Molecular activatable probes with near‐infrared (NIR) fluorescence play a critical role in in vivo imaging of biomarkers for drug screening and disease diagnosis. With structural diversity and high fluorescence quantum yields, hemicyanine dyes have emerged as a versatile scaffold for the constructio...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 60; no. 51; pp. 26454 - 26475 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Germany
Wiley Subscription Services, Inc
13.12.2021
|
Edition | International ed. in English |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Molecular activatable probes with near‐infrared (NIR) fluorescence play a critical role in in vivo imaging of biomarkers for drug screening and disease diagnosis. With structural diversity and high fluorescence quantum yields, hemicyanine dyes have emerged as a versatile scaffold for the construction of activatable optical probes. This Review presents a survey of hemicyanine‐based NIR activatable probes (HNAPs) for in vivo imaging and early diagnosis of diseases. The molecular design principles of HNAPs towards activatable optical signaling against various biomarkers are discussed with a focus on their broad applications in the detection of diseases including inflammation, acute organ failure, skin diseases, intestinal diseases, and cancer. This progress not only proves the unique value of HNAPs in preclinical research but also highlights their high translational potential in clinical diagnosis.
Near‐infrared fluorescent hemicyanines, known for their structural diversity, high fluorescence quantum yields, and good biocompatibility, are attractive scaffolds for the construction of activatable optical probes for disease diagnosis. This Review discusses the design strategies and sensing mechanisms of these probes, with an emphasis on their applications in early disease detection and imaging‐guided therapies. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.202107877 |